Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Reddit
RDDT
|
$196M |
| 2 |
Nike
NKE
|
$183M |
| 3 |
Alibaba
BABA
|
$172M |
| 4 |
Shopify
SHOP
|
$167M |
| 5 |
TSMC
TSM
|
$154M |
Top Sells
| 1 |
Palantir
PLTR
|
$1.18B |
| 2 |
Microsoft
MSFT
|
$678M |
| 3 |
Meta Platforms (Facebook)
META
|
$350M |
| 4 |
Apple
AAPL
|
$202M |
| 5 |
Micron Technology
MU
|
$202M |
Sector Composition
| 1 | Technology | 20.89% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 14.08% |
| 4 | Industrials | 8.96% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Veeva Systems
VEEV
$44.7B
| $42.3M | 0.06% |
201,200
+122,000
| +154% | +$25.7M |
|
377
Shell
SHEL
$208B
| $42.2M | 0.06% |
673,786
-12,200
| -2% | -$764K |
|
378
Vimeo
VMEO
$734M
| $42.2M | 0.06% |
6,590,500
+419,700
| +7% | +$2.69M |
|
379
Moderna
MRNA
$9.78B
| $42M | 0.06% |
1,010,758
+700,458
| +226% | +$29.1M |
|
380
Hess Midstream
HESM
$5.34B
| $42M | 0.06% |
1,134,495
+30,200
| +3% | +$1.12M |
|
381
Travere Therapeutics
TVTX
$1.93B
| $42M | 0.06% |
2,409,514
+534,500
| +29% | +$9.31M |
|
382
Eli Lilly
LLY
$652B
| $41.8M | 0.06% |
54,120
-203,693
| -79% | -$157M |
|
383
Insulet
PODD
$24.5B
| $41.5M | 0.06% |
158,993
+49,900
| +46% | +$13M |
|
384
Clearwater Analytics
CWAN
$6.07B
| $41.5M | 0.06% |
1,507,900
+1,202,900
| +394% | +$33.1M |
|
385
US Foods
USFD
$17.5B
| $41.3M | 0.06% |
612,000
+432,200
| +240% | +$29.2M |
|
386
National Healthcare
NHC
$1.78B
| $41.1M | 0.06% |
381,867
-9,400
| -2% | -$1.01M |
|
387
Wabtec
WAB
$33B
| $40.8M | 0.06% |
215,395
-173,000
| -45% | -$32.8M |
|
388
Takeda Pharmaceutical
TAK
$48.6B
| $40.8M | 0.06% |
3,079,400
-139,400
| -4% | -$1.85M |
|
389
Raymond James Financial
RJF
$33B
| $40.7M | 0.06% |
262,037
+69,000
| +36% | +$10.7M |
|
390
Chord Energy
CHRD
$5.92B
| $40.6M | 0.06% |
347,216
+138,600
| +66% | +$16.2M |
|
391
International Flavors & Fragrances
IFF
$16.9B
| $40.5M | 0.06% |
478,601
-28,099
| -6% | -$2.38M |
|
392
Westlake Corp
WLK
$11.5B
| $40.2M | 0.06% |
350,700
+182,600
| +109% | +$20.9M |
|
393
Genmab
GMAB
$16.9B
| $40.2M | 0.06% |
1,926,150
+139,722
| +8% | +$2.92M |
|
394
Louisiana-Pacific
LPX
$6.9B
| $40.2M | 0.06% |
388,200
-46,686
| -11% | -$4.83M |
|
395
Descartes Systems
DSGX
$9.26B
| $40.2M | 0.06% |
353,800
-15,900
| -4% | -$1.81M |
|
396
Ironwood Pharmaceuticals
IRWD
$188M
| $40.2M | 0.06% |
9,066,241
+469,043
| +5% | +$2.08M |
|
397
Brookfield Renewable
BEPC
$5.96B
| $40.1M | 0.06% |
1,449,495
-76,700
| -5% | -$2.12M |
|
398
Under Armour
UAA
$2.2B
| $40.1M | 0.06% |
4,837,800
+581,800
| +14% | +$4.82M |
|
399
Skywest
SKYW
$4.81B
| $40M | 0.06% |
399,324
+128,524
| +47% | +$12.9M |
|
400
JD.com
JD
$44.6B
| $39.7M | 0.06% |
1,143,700
+1,063,800
| +1,331% | +$36.9M |
|